Open AccessPrevalence of Cannabinoid Use in Patients With Hip and Knee Osteoarthritis
Author(s) -
David G. Deckey,
Nina Lara,
Matthew T. Gulbrandsen,
Jeffrey D. Hassebrock,
Mark J. Spangehl,
Joshua S. Bingham
Publication year - 2021
Publication title -
journal of the american academy of orthopaedic surgeons. global research and reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.358
H-Index - 2
ISSN - 2474-7661
DOI - 10.5435/jaaosglobal-d-20-00172
Subject(s) - medicine , osteoarthritis , physical therapy , dispensary , knee pain , alternative medicine , family medicine , pathology
State legalization and widespread marketing efforts have increased the accessibility and consumption of off-label, non-FDA-approved, cannabinoid (CBD) products. Although clinical evidence is largely absent for the treatment of musculoskeletal pain, patients are experimenting with these products in efforts to relieve joint pain. Assessment of the prevalence, perceived efficacy compared with other nonsurgical modalities, and usage patterns is warranted. The purpose of this study was to report the prevalence and perceived self-efficacy of CBD products in patients with symptomatic hip and/or knee osteoarthritis (OA).